| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 532,300 | | Cost of Revenue | 287,000 | | | Gross Profit | 245,300 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 149,400 | | Non Recurring | 1,900 | | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 94,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| | Earnings Before Interest And Taxes | 94,000 | | Interest Expense | 600 | | Income Before Tax | 93,400 | | Income Tax Expense | 36,300 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 57,100 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 57,100 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $57,100 |
|
0.49% Nasdaq 
Income Statement
